Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ResMed Doubles Down On Connected Care With $800m Brightree Acquisition

Executive Summary

Resmed continues its push to integrate healthcare analytics and cloud-based software into its respiratory management devices with its proposed $800m acquisition of Brightree, a developer of cloud-based software for improving clinical and business performance for providers of post-acute care. The move expands ResMed's offerings to its core HME/DME sleep customers and opens doors in new market segments, including home health and hospital channels, where there is a high prevalence of sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.

Advertisement

Related Content

Earnings Winners & Losers, Medtech 'Pure-Plays' BSX, ISRG, BDX, VAR, RMD,

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT035998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel